|
Pembrolizumab infusion Clinical Trials
2 actively recruiting trials across 1 location
Also known as: Checkpoint blockade administration, Keytruda
Philadelphia, Pennsylvania2 trials
BreastVAX: Radiation Boost to Enhance Immune Checkpoint Blockade Therapy
Perelman Center for Advanced Medicine
Phase 1/2
Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell Carcinoma
Abramson Cancer Center at University of Pennsylvania
Early 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.